Evidence map›Paper›PMID 29737249›Full record

ReviewCurrent medicinal chemistry2019

Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development.

Mark R Swingle, Richard E Honkanen

Open access · greenAbstract readReview
In one paragraph

Review in Current medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Quantum-based modeling implies that bidentate ArgFrontiers in cell and developmental biology · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mark R SwingleDepartment of Biochemistry and Molecular Biology, University of South Alabama, Mobile AL 36688, United States.
Richard E HonkanenDepartment of Biochemistry and Molecular Biology, University of South Alabama, Mobile AL 36688, United States.
University of South Alabama · US

Funding

MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESISR01CA060750 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 1999 to 2009
$2.5M
Development of a HTS-assay for inhibitors of a type 2C protein phosphatase (PPMR21NS071553 · NINDS · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 2010 to 2010
$148k
HTP screening for inhibitors of ser/the protein phosphatase 5R03MH085702 · NIMH · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 2009 to 2009
$25k
NCI NIH HHS R01 CA060750NIMH NIH HHS R03 MH085702NINDS NIH HHS R21 NS071553
6 · The paper itself

Abstract

backgroundThe reversible phosphorylation of proteins regulates many key functions in eukaryotic cells. Phosphorylation is catalyzed by protein kinases, with the majority of phosphorylation occurring on side chains of serine and threonine residues. The phosphomonoesters generated by protein kinases are hydrolyzed by protein phosphatases. In the absence of a phosphatase, the half-time for the hydrolysis of alkyl phosphate dianions at 25º C is over 1 trillion years; knon ~2 x 10-20 sec-1. Therefore, ser/thr phosphatases are critical for processes controlled by reversible phosphorylation.

methodsThis review is based on the literature searched in available databases. We compare the catalytic mechanism of PPP-family phosphatases (PPPases) and the interactions of inhibitors that target these enzymes.

resultsPPPases are metal-dependent hydrolases that enhance the rate of hydrolysis ([kcat/kM]/knon ) by a factor of ~1021, placing them among the most powerful known catalysts on earth. Biochemical and structural studies indicate that the remarkable catalytic proficiencies of PPPases are achieved by 10 conserved amino acids, DXH(X)~26DXXDR(X)~20- 26NH(X)~50H(X)~25-45R(X)~30-40H. Six act as metal-coordinating residues. Four position and orient the substrate phosphate. Together, two metal ions and the 10 catalytic residues position the phosphoryl group and an activated bridging water/hydroxide nucleophile for an inline attack upon the substrate phosphorous atom. The PPPases are conserved among species, and many structurally diverse natural toxins co-evolved to target these enzymes.

conclusionAlthough the catalytic site is conserved, opportunities for the development of selective inhibitors of this important group of metalloenzymes exist.

Indexed as

AnimalsCatalysisCatalytic DomainEnzyme InhibitorsHumansIsoenzymesPhosphoprotein PhosphatasesProtein BindingProtein DomainsEnzyme InhibitorsIsoenzymesPhosphoprotein Phosphatasescantharidinfostriecininhibitormicrocystin crystal structuresokadaic acidPhosphatasetautomycin.

Identifiers

PMID29737249
PMCPMC10013172
OpenAlexW2803045876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.